Location History:
- Birmingham, GB (2006)
- Hall Green, GB (2006)
- Oxford, GB (2007 - 2012)
Company Filing History:
Years Active: 2006-2012
Title: The Innovative Contributions of Vilasben Kanji Shah
Introduction
Vilasben Kanji Shah is a prominent inventor based in Oxford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various health conditions. With a total of 10 patents to his name, Shah's work has the potential to impact the treatment of obesity and diabetes.
Latest Patents
Shah's latest patents include innovative compounds that serve as G-protein coupled receptor agonists. These compounds, described as Formula (I) or pharmaceutically acceptable salts or N-oxides thereof, are specifically agonists of GPR116 and are useful for treating obesity and diabetes. Another notable patent involves substituted phenylacetamides, which are glucokinase activators. These compounds, also defined by Formula (I) where R is a cycloalkylsulphonyl group, are beneficial in the prophylactic and therapeutic treatment of hyperglycemia and diabetes.
Career Highlights
Throughout his career, Shah has worked with reputable companies such as Warner-Lambert Company and Prosidion Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas, leading to the successful patenting of his inventions.
Collaborations
Some of Shah's notable coworkers include Matthew Colin Thor Fyfe and Martin James Procter. Their collaboration has likely contributed to the advancement of research and development in their respective fields.
Conclusion
Vilasben Kanji Shah's contributions to pharmaceutical innovations demonstrate his commitment to improving health outcomes through scientific research. His patents reflect a deep understanding of complex biological mechanisms and a dedication to addressing critical health issues.